Lanchon R, Robin F, Brissaud O, Marro M, Nouette-Gaulain K
Service d'anesthésie réanimation 3, pôle d'anesthésie réanimation, CHU de Bordeaux, 33076 Bordeaux, France.
Service d'anesthésie réanimation 3, pôle d'anesthésie réanimation, CHU de Bordeaux, 33076 Bordeaux, France.
Ann Fr Anesth Reanim. 2014 Mar;33(3):e43-5. doi: 10.1016/j.annfar.2014.01.005. Epub 2014 Feb 21.
Combined factors V (FV) and VIII (FVIII) deficiency is a rarely seen hereditary coagulation disease. Experience of its management in surgery with a high-risk of bleeding is rare. The interest of this case report is to propose a strategy of perioperative management for such a deficit, but also to recall that a careful preoperative anesthetic evaluation with questioning and physical examination permits to detect unsuspected coagulation disorders and to schedule the preventive treatment. The protocol for the perioperative period consisted of the administration of desmopressin and fresh frozen plasma one hour before surgery. The administration of desmopressin was continued for 48hours. Fresh frozen plasma and tranexamic acid were administered during the first 9 postoperative days. A local bleeding occurred at 8 days (scab coming off) and required systematically a surgical hemostasis and an intensification of the therapeutic protocol. Recombinant plasmatic factor VIII was administered for 7 days together with a daily perfusion of fresh frozen plasma for a total treatment period of 14 days.
联合因子V(FV)和因子VIII(FVIII)缺乏是一种罕见的遗传性凝血疾病。在具有高出血风险的手术中对其进行管理的经验很少。本病例报告的意义在于提出针对这种缺乏症的围手术期管理策略,同时也要提醒大家,通过仔细的术前麻醉评估,包括询问病史和体格检查,能够发现未被怀疑的凝血障碍,并安排预防性治疗。围手术期方案包括在手术前1小时给予去氨加压素和新鲜冰冻血浆。去氨加压素持续给药48小时。在术后的前9天给予新鲜冰冻血浆和氨甲环酸。术后第8天出现局部出血(痂皮脱落),需要进行系统性的手术止血并强化治疗方案。重组血浆因子VIII给药7天,同时每天输注新鲜冰冻血浆,总治疗期为14天。